Eur J Pediatr Surg 2016; 26(01): 100-105
DOI: 10.1055/s-0035-1566099
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Effectiveness of Rectal Suction Biopsy in Diagnosing Hirschsprung Disease

Claudia M. G. Keyzer-Dekker
1   Department of Pediatric Surgery, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands
,
Cornelius E. Sloots
1   Department of Pediatric Surgery, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands
,
Irene K. Schokker-van Linschoten
1   Department of Pediatric Surgery, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands
,
Katharina Biermann
2   Department of Pathology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands
,
Conny Meeussen
1   Department of Pediatric Surgery, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands
,
Michael Doukas
2   Department of Pathology, Erasmus MC-Sophia Children's Hospital, Rotterdam, The Netherlands
› Author Affiliations
Further Information

Publication History

24 May 2015

31 August 2015

Publication Date:
27 October 2015 (online)

Abstract

Introduction Rectal suction biopsy (RSB) is performed on clinical and radiological suspicion of Hirschsprung disease (HD). Positive histochemical staining for acetylcholinesterase in the lamina propria mucosa and muscularis mucosa together with the absence of ganglion cells in the submucosa confirms HD. A second RSB or a full-thickness biopsy is done in case of doubt. The primary aim of the study was to evaluate the effectiveness of RSB in diagnosing HD. In addition, the results of RSB in preterm born infants were analyzed.

Methods This retrospective study included all infants younger than 1 year who had RSB for HD suspicion from January 2004 to April 2014. All histopathological results were reviewed. Sensitivity, specificity, positive, and negative predictive values of the first RSB were calculated.

Results In total, 183 patients (99 boys, mean age 11 weeks) were included. HD was diagnosed in 55 patients (30%). A second biopsy was performed in 12/55 patients (22%), which confirmed HD in 9 patients. One patient did not undergo a second biopsy, but HD was excluded based on clinical follow-up. Thus, HD was eventually excluded in 4 of the 55 patients with a positive first RSB. HD was excluded in the first biopsy in 128 patients (70%). In 19 of those (15%), a second biopsy was done, which led to the diagnosis of HD in 10 patients. Two patients with negative biopsy results were still operated on because of the high clinical suspicion for HD, and the histopathological analysis on the operative specimen confirmed HD. Thus, HD was eventually diagnosed in 12 out of 128 patients. Thus, the sensitivity of the first RSB was 81% and the specificity was 97%. The positive predictive value was 93% and the negative predictive value was 91%. A subanalysis for the 38 preterm born infants was done, with a mean conceptional age at the time of biopsy of 44 weeks (range 34–82). Sensitivity and specificity of RSB were 83 and 97%, respectively, with one false-positive and one false-negative results.

Conclusion The overall sensitivity of the RSB was 81%, with 12 false-negative results, in which cases extra biopsies had been necessary. The specificity was 97%, with four false-positive findings. We found that RSB can also be reliably and safely performed in preterm born infants, which implies there is no reason to postpone a RSB in those infants. New methods, such as calretinin staining, must be considered to achieve better effectiveness of the RSB for diagnosing HD.

 
  • References

  • 1 Puri P. Hirschsprung's disease. In: Puri P, Hollwarth ME, eds. Pediatric Surgery. 1st ed. New York: Springer Verlag; 2006: 275-288
  • 2 de Lorijn F, Kremer LC, Reitsma JB, Benninga MA. Diagnostic tests in Hirschsprung disease: a systematic review. J Pediatr Gastroenterol Nutr 2006; 42 (5) 496-505
  • 3 Dobbins III WO, Bill Jr AH. Diagnosis of Hirschsprung disease excluded by rectal suction biopsy. N Engl J Med 1965; 272: 990-993
  • 4 Campbell PE, Noblett HR. Experience with rectal suction biopsy in the diagnosis of Hirschsprung's disease. J Pediatr Surg 1969; 4 (4) 410-415
  • 5 Meier-Ruge W, Lutterbeck PM, Herzog B, Morger R, Moser R, Schärli A. Acetylcholinesterase activity in suction biopsies of the rectum in the diagnosis of Hirschsprung's disease. J Pediatr Surg 1972; 7 (1) 11-17
  • 6 De Lorijn F, Reitsma JB, Voskuijl WP , et al. Diagnosis of Hirschsprung's disease: a prospective, comparative accuracy study of common tests. J Pediatr 2005; 146 (6) 787-792
  • 7 Kaiser GL. Constipation. In: Kaiser GL, ed. Symptoms and Signs in Pediatric Surgery. 1st ed. Berlin, Heidelberg: Springer Verlag; 2012: 359-374
  • 8 de Brito IA, Maksoud JG. Evolution with age of the acetylcholinesterase activity in rectal suction biopsy in Hirschsprung's disease. J Pediatr Surg 1987; 22 (5) 425-430
  • 9 Noblett HR. A rectal suction biopsy tube for use in the diagnosis of Hirschsprung's disease. J Pediatr Surg 1969; 4 (4) 406-409
  • 10 Barshack I, Fridman E, Goldberg I, Chowers Y, Kopolovic J. The loss of calretinin expression indicates aganglionosis in Hirschsprung's disease. J Clin Pathol 2004; 57 (7) 712-716
  • 11 de Arruda Lourenção PL, Takegawa BK, Ortolan EV, Terra SA, Rodrigues MA. Does calretinin immunohistochemistry reduce inconclusive diagnosis in rectal biopsies for Hirschsprung disease?. J Pediatr Gastroenterol Nutr 2014; 58 (5) 603-607
  • 12 Kapur RP. Can we stop looking? Immunohistochemistry and the diagnosis of Hirschsprung disease. Am J Clin Pathol 2006; 126 (1) 9-12
  • 13 Hamoudi AB, Reiner CB, Boles Jr ET, McClung HJ, Kerzner B. Acetylthiocholinesterase staining activity of rectal mucosa. Its use in the diagnosis of Hirschsprung's disease. Arch Pathol Lab Med 1982; 106 (13) 670-672
  • 14 Gonzalo DH, Plesec T. Hirschsprung disease and use of calretinin in inadequate rectal suction biopsies. Arch Pathol Lab Med 2013; 137 (8) 1099-1102
  • 15 Holland SK, Ramalingam P, Podolsky RH, Reid-Nicholson MD, Lee JR. Calretinin immunostaining as an adjunct in the diagnosis of Hirschsprung disease. Ann Diagn Pathol 2011; 15 (5) 323-328
  • 16 Alexandrescu S, Rosenberg H, Tatevian N. Role of calretinin immunohistochemical stain in evaluation of Hirschsprung disease: an institutional experience. Int J Clin Exp Pathol 2013; 6 (12) 2955-2961
  • 17 Kapur RP, Reed RC, Finn LS, Patterson K, Johanson J, Rutledge JC. Calretinin immunohistochemistry versus acetylcholinesterase histochemistry in the evaluation of suction rectal biopsies for Hirschsprung Disease. Pediatr Dev Pathol 2009; 12 (1) 6-15
  • 18 Guinard-Samuel V, Bonnard A, De Lagausie P , et al. Calretinin immunohistochemistry: a simple and efficient tool to diagnose Hirschsprung disease. Mod Pathol 2009; 22 (10) 1379-1384
  • 19 Małdyk J, Rybczyńska J, Piotrowski D, Kozielski R. Evaluation of calretinin immunohistochemistry as an additional tool in confirming the diagnosis of Hirschsprung disease. Pol J Pathol 2014; 65 (1) 34-39
  • 20 Yadav L, Kini U, Das K, Mohanty S, Puttegowda D. Calretinin immunohistochemistry versus improvised rapid acetylcholinesterase histochemistry in the evaluation of colorectal biopsies for Hirschsprung disease. Indian J Pathol Microbiol 2014; 57 (3) 369-375
  • 21 Bachmann L, Besendörfer M, Carbon R , et al. Immunohistochemical panel for the diagnosis of Hirschsprung's disease using antibodies to MAP2, calretinin, GLUT1 and S100. Histopathology 2015; 66 (6) 824-835
  • 22 Meier-Ruge W, Bruder E. Histopathological diagnosis and differential diagnosis of Hirschsprung's disease. In: Holschneider AM, Puri P, eds. Hirschsprung's Disease and Allied Disorders. 3th ed. New York: Springer Verlag; 2007: 185-197
  • 23 Duess JW, Hofmann AD, Puri P. Prevalence of Hirschsprung's disease in premature infants: a systematic review. Pediatr Surg Int 2014; 30 (8) 791-795
  • 24 Friedmacher F, Puri P. Rectal suction biopsy for the diagnosis of Hirschsprung's disease: a systematic review of diagnostic accuracy and complications. Pediatr Surg Int 2015; 31 (9) 821-830